Optic neuritis associated with adalimumab in the treatment of uveitis
- PMID: 20809867
- DOI: 10.3109/09273948.2010.495814
Optic neuritis associated with adalimumab in the treatment of uveitis
Abstract
Background: Tumor necrosis factor (TNF) inhibitors such as adalimumab are increasingly used in the treatment of ocular inflammatory disease refractory to standard therapies. There is evidence that TNF inhibitors are associated with demyelinating neurologic events.
Objective: The authors report a case of optic neuritis and multiple sclerosis developing in association with the use of adalimumab for the treatment of bilateral chronic granulomatous iridocyclitis and multifocal choroiditis. They also review the available literature on cases of optic neuritis occurring in the setting of TNF inhibition.
Results: The authors identified 21 cases of optic neuritis associated with TNF inhibition; 36% of cases with available MRI results had evidence of other demyelinating lesions in the CNS.
Conclusions: The strong association between TNF inhibitors and CNS demyelination may represent an adverse effect of these drugs. Ophthalmologists should recognize the relationship between TNF inhibitors and demyelinating disease, as it can present initially with visual symptoms.
Comment in
-
TNF inhibitors for uveitis: balancing efficacy and safety.Ocul Immunol Inflamm. 2010 Dec;18(6):421-3. doi: 10.3109/09273948.2010.531176. Ocul Immunol Inflamm. 2010. PMID: 21091055 No abstract available.
Similar articles
-
Adalimumab-associated optic neuritis.J Neurol Sci. 2006 May 15;244(1-2):133-6. doi: 10.1016/j.jns.2006.01.012. Epub 2006 Mar 9. J Neurol Sci. 2006. PMID: 16527311
-
Adalimumab-associated multiple sclerosis.J Rheumatol. 2007 Jan;34(1):239-40; discussion 240. J Rheumatol. 2007. PMID: 17216704 No abstract available.
-
TNF inhibitors for uveitis: balancing efficacy and safety.Ocul Immunol Inflamm. 2010 Dec;18(6):421-3. doi: 10.3109/09273948.2010.531176. Ocul Immunol Inflamm. 2010. PMID: 21091055 No abstract available.
-
Evolving management of optic neuritis and multiple sclerosis.Am J Ophthalmol. 2005 Jun;139(6):1101-8. doi: 10.1016/j.ajo.2005.01.031. Am J Ophthalmol. 2005. PMID: 15953446 Review.
-
Clinical practice. Optic neuritis.N Engl J Med. 2006 Mar 23;354(12):1273-80. doi: 10.1056/NEJMcp053247. N Engl J Med. 2006. PMID: 16554529 Review. No abstract available.
Cited by
-
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease - A Case Series.J Ophthalmic Inflamm Infect. 2024 Jul 30;14(1):35. doi: 10.1186/s12348-024-00403-3. J Ophthalmic Inflamm Infect. 2024. PMID: 39078559 Free PMC article.
-
Intravenous Immunoglobulin in the Treatment of Adalimumab-associated Optic Neuritis.Intern Med. 2022 Feb 1;61(3):429-432. doi: 10.2169/internalmedicine.7599-21. Epub 2021 Aug 6. Intern Med. 2022. PMID: 34373376 Free PMC article.
-
Bacille Calmette-Guérin: An ophthalmic perspective.Surv Ophthalmol. 2022 Mar-Apr;67(2):307-320. doi: 10.1016/j.survophthal.2021.07.005. Epub 2021 Jul 31. Surv Ophthalmol. 2022. PMID: 34343536 Free PMC article. Review.
-
Infliximab-induced optic neuritis.BMJ Case Rep. 2020 Dec 22;13(12):e236041. doi: 10.1136/bcr-2020-236041. BMJ Case Rep. 2020. PMID: 33370961 Free PMC article.
-
Acute Inflammatory Optic Neuritis Associated with a Self-Taper of Oral Prednisone in a Patient Taking Adalimumab.Neuroophthalmology. 2019 Jan 18;44(3):186-189. doi: 10.1080/01658107.2019.1566386. eCollection 2020 Jun. Neuroophthalmology. 2019. PMID: 32395171 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
